Skip to main content
. 2017 Jan 26;12(1):e0170960. doi: 10.1371/journal.pone.0170960

Fig 5. CA modulated AKR1D1 expression in time and dose-dependent manners in HepG2 cells.

Fig 5

(A) HepG2 cells were treated with either CA (25 μM) or vehicle DMSO for 8, 24 or 30 hrs, followed by detection of AKR1D1 mRNA with real-time PCR. (B) HepG2 cells were treated with various concentrations of CA (0, 5, 25, 50, 100, 200 μM) for 30 hrs, followed by detection of AKR1D1 mRNA expression with real-time PCR. *p<0.05 with the Student’s t-test for pair-wise comparison.